Bacalso, Bonifacio R.
HRN: 28-29-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
CEFTRIAXONE 1G (VIAL)
12/17/2025
12/24/2025
IV
2g
OD
CAPMR; UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary TractPneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes